Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).

The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery

News | Cardiovascular Surgery

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

February 26, 2024

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002

Feature | Cardiovascular Surgery

In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transca ...

February 23, 2024

The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.

News | FDA

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

February 02, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease

Feature

Spotlight on Advancements in Mitral Valve Repair, Research

You may not know Carol Barr, but in the future, she could save your life.

Barr’s death at 39 from sudden cardiac ...

January 24, 2024

Five implants successfully accomplished at the Instituto Nacional de Torax in Santiago, Chile with advanced engineered heart valve, ZETA, designed to provide flexibility and optionality regardless of high, low or zero calcification

News | Structural Heart

Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial

January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...

January 04, 2024

Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.

News | Heart Valve Technology

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

January 04, 2024

TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.

News | Heart Valve Technology

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

December 22, 2023

Substance use disorder may be linked to more deaths from infective endocarditis among people ages 25-44, finds new study in Journal of the American Heart Association

News | Heart Valve Technology

Deaths from Heart Valve Infections Drop Across US Overall, but Surged Among Young Adults

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

December 18, 2023

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.

News | Heart Valve Technology

Use of Anticoagulant Drug after Aortic Valve Replacement Lowers Mortality Risk, Mayo Clinic Study Finds

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement h ...

December 12, 2023

New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots

News | Heart Valve Technology

Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its He ...

November 20, 2023

Team Bath Heart’s artificial heart wins top prize at international engineering & design contest

News | Artificial Heart

Heart of Gold: Bath Student Team Wins World Heart Hackathon Competition

November 20, 2023 — Student engineers from the University of Bath are on top of the world after winning an international ...

November 20, 2023

News | Artificial Heart

Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference

November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has ...

November 10, 2023

News | TCT

Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

October 26, 2023

Figure 1: A PROTECT III study analysis demonstrates that 82.5% of Impella-supported HRPCI patients have features in all three high-risk factor domains – comorbidities, complex coronary anatomy and adverse hemodynamics.

News | Heart Valve Technology

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium

October 24, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

October 24, 2023

Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation

News | Structural Heart

Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark

October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system ...

October 19, 2023